array(40) {
  [0]=>
  string(4) "8606"
  ["article_id"]=>
  string(4) "8606"
  [1]=>
  string(78) "Coloplast A/S - Transaktioner i henhold til aktietilbagekøbsprogram, uge 13"
  ["article_title"]=>
  string(78) "Coloplast A/S - Transaktioner i henhold til aktietilbagekøbsprogram, uge 13"
  [2]=>
  string(133) "Som meddelt i Selskabsmeddelelse nr. 02/2020 har Coloplast iværksat et tilbagekøbsprogram på i alt 500 millioner kroner. "
  ["short_description"]=>
  string(133) "Som meddelt i Selskabsmeddelelse nr. 02/2020 har Coloplast iværksat et tilbagekøbsprogram på i alt 500 millioner kroner. "
  [3]=>
  string(144) "
Som meddelt i Selskabsmeddelelse nr. 02/2020 har Coloplast iværksat et tilbagekøbsprogram på i alt 500 millioner kroner. 
"
  ["description"]=>
  string(144) "
Som meddelt i Selskabsmeddelelse nr. 02/2020 har Coloplast iværksat et tilbagekøbsprogram på i alt 500 millioner kroner. 
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(148) "http://www.globenewswire.com/news-release/2020/03/30/2008149/0/da/Coloplast-A-S-Transaktioner-i-henhold-til-aktietilbagek%C3%B8bsprogram-uge-13.html"
  ["blog_url"]=>
  string(148) "http://www.globenewswire.com/news-release/2020/03/30/2008149/0/da/Coloplast-A-S-Transaktioner-i-henhold-til-aktietilbagek%C3%B8bsprogram-uge-13.html"
  [15]=>
  string(19) "2020-03-30 17:49:00"
  ["add_date"]=>
  string(19) "2020-03-30 17:49:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:24"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8686"
  ["article_id"]=>
  string(4) "8686"
  [1]=>
  string(65) "Survey results suggest medtech companies are not ready for EU MDR"
  ["article_title"]=>
  string(65) "Survey results suggest medtech companies are not ready for EU MDR"
  [2]=>
  string(117) "Software company Climedo Health has announced the results of its EU Medical Device Regulation (MDR) Readiness Survey."
  ["short_description"]=>
  string(117) "Software company Climedo Health has announced the results of its EU Medical Device Regulation (MDR) Readiness Survey."
  [3]=>
  string(117) "Software company Climedo Health has announced the results of its EU Medical Device Regulation (MDR) Readiness Survey."
  ["description"]=>
  string(117) "Software company Climedo Health has announced the results of its EU Medical Device Regulation (MDR) Readiness Survey."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/survey-results-suggest-many-medtech-companies-are-not-ready-/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/survey-results-suggest-many-medtech-companies-are-not-ready-/"
  [15]=>
  string(19) "2020-03-30 17:44:25"
  ["add_date"]=>
  string(19) "2020-03-30 17:44:25"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8487"
  ["article_id"]=>
  string(4) "8487"
  [1]=>
  string(64) "Common Heart Drugs' Risk With COVID-19 Unproven, Experts Say"
  ["article_title"]=>
  string(64) "Common Heart Drugs' Risk With COVID-19 Unproven, Experts Say"
  [2]=>
  string(153) "MONDAY, March 30, 2020 -- Could a blood pressure or diabetes medicine make COVID-19 more severe?&#nlA proposed new theory says the coronavirus could be b"
  ["short_description"]=>
  string(153) "MONDAY, March 30, 2020 -- Could a blood pressure or diabetes medicine make COVID-19 more severe?&#nlA proposed new theory says the coronavirus could be b"
  [3]=>
  string(247) "MONDAY, March 30, 2020 -- Could a blood pressure or diabetes medicine make COVID-19 more severe?&#nlA proposed new theory says the coronavirus could be binding to angiotensin converting enzyme 2 (ACE2) receptors in the lower respiratory tracts...."
  ["description"]=>
  string(247) "MONDAY, March 30, 2020 -- Could a blood pressure or diabetes medicine make COVID-19 more severe?&#nlA proposed new theory says the coronavirus could be binding to angiotensin converting enzyme 2 (ACE2) receptors in the lower respiratory tracts...."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(193) "https://www.drugs.com/news/common-heart-risk-covid-19-unproven-experts-say-89261.html?utm_source=ddc&utm_medium=rss&utm_campaign=Common+Heart+Drugs%27+Risk+With+COVID-19+Unproven%2C+Experts+Say"
  ["blog_url"]=>
  string(193) "https://www.drugs.com/news/common-heart-risk-covid-19-unproven-experts-say-89261.html?utm_source=ddc&utm_medium=rss&utm_campaign=Common+Heart+Drugs%27+Risk+With+COVID-19+Unproven%2C+Experts+Say"
  [15]=>
  string(19) "2020-03-30 17:03:59"
  ["add_date"]=>
  string(19) "2020-03-30 17:03:59"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:17:59"
  ["create_at"]=>
  string(19) "2020-03-31 11:17:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8488"
  ["article_id"]=>
  string(4) "8488"
  [1]=>
  string(51) "A Parent's Guide to Fighting Coronavirus Stress"
  ["article_title"]=>
  string(51) "A Parent's Guide to Fighting Coronavirus Stress"
  [2]=>
  string(153) "MONDAY, March 30, 2020 -- Stressed-out parents should reach out to others for support during the coronavirus pandemic, child health experts say.&#nlAs th"
  ["short_description"]=>
  string(153) "MONDAY, March 30, 2020 -- Stressed-out parents should reach out to others for support during the coronavirus pandemic, child health experts say.&#nlAs th"
  [3]=>
  string(249) "MONDAY, March 30, 2020 -- Stressed-out parents should reach out to others for support during the coronavirus pandemic, child health experts say.&#nlAs the number of coronavirus cases rise and families spend long periods in isolation, parents face..."
  ["description"]=>
  string(249) "MONDAY, March 30, 2020 -- Stressed-out parents should reach out to others for support during the coronavirus pandemic, child health experts say.&#nlAs the number of coronavirus cases rise and families spend long periods in isolation, parents face..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(173) "https://www.drugs.com/news/parent-s-guide-fighting-coronavirus-stress-89263.html?utm_source=ddc&utm_medium=rss&utm_campaign=A+Parent%27s+Guide+to+Fighting+Coronavirus+Stress"
  ["blog_url"]=>
  string(173) "https://www.drugs.com/news/parent-s-guide-fighting-coronavirus-stress-89263.html?utm_source=ddc&utm_medium=rss&utm_campaign=A+Parent%27s+Guide+to+Fighting+Coronavirus+Stress"
  [15]=>
  string(19) "2020-03-30 17:03:13"
  ["add_date"]=>
  string(19) "2020-03-30 17:03:13"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:17:59"
  ["create_at"]=>
  string(19) "2020-03-31 11:17:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8489"
  ["article_id"]=>
  string(4) "8489"
  [1]=>
  string(33) "Health Highlights: March 30, 2020"
  ["article_title"]=>
  string(33) "Health Highlights: March 30, 2020"
  [2]=>
  string(156) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nl66 Coronavirus Cases in Maryland Nursing Home&#nl"
  ["short_description"]=>
  string(156) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nl66 Coronavirus Cases in Maryland Nursing Home&#nl"
  [3]=>
  string(253) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nl66 Coronavirus Cases in Maryland Nursing Home&#nlCoronavirus has been confirmed in 66 residents of a Maryland nursing home, and 11 of them have..."
  ["description"]=>
  string(253) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nl66 Coronavirus Cases in Maryland Nursing Home&#nlCoronavirus has been confirmed in 66 residents of a Maryland nursing home, and 11 of them have..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(150) "https://www.drugs.com/news/health-highlights-march-30-2020-89265.html?utm_source=ddc&utm_medium=rss&utm_campaign=Health+Highlights%3A+March+30%2C+2020"
  ["blog_url"]=>
  string(150) "https://www.drugs.com/news/health-highlights-march-30-2020-89265.html?utm_source=ddc&utm_medium=rss&utm_campaign=Health+Highlights%3A+March+30%2C+2020"
  [15]=>
  string(19) "2020-03-30 16:03:55"
  ["add_date"]=>
  string(19) "2020-03-30 16:03:55"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:17:59"
  ["create_at"]=>
  string(19) "2020-03-31 11:17:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8734"
  ["article_id"]=>
  string(4) "8734"
  [1]=>
  string(86) "COVID-19: 'A continuously evolving process that requires adapting by the hour'"
  ["article_title"]=>
  string(86) "COVID-19: 'A continuously evolving process that requires adapting by the hour'"
  [2]=>
  string(150) "As the number of lives touched by COVID-19 is continuously mounting, so are the efforts of IT departments to counter the rising pressure on hospitals."
  ["short_description"]=>
  string(150) "As the number of lives touched by COVID-19 is continuously mounting, so are the efforts of IT departments to counter the rising pressure on hospitals."
  [3]=>
  string(154) "As the number of lives touched by COVID-19 is continuously mounting, so are the efforts of IT departments to counter the rising pressure on hospitals.&#nl"
  ["description"]=>
  string(154) "As the number of lives touched by COVID-19 is continuously mounting, so are the efforts of IT departments to counter the rising pressure on hospitals.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(106) "https://www.healthcareitnews.com/news/europe/covid-19-continuously-evolving-process-requires-adapting-hour"
  ["blog_url"]=>
  string(106) "https://www.healthcareitnews.com/news/europe/covid-19-continuously-evolving-process-requires-adapting-hour"
  [15]=>
  string(19) "2020-03-30 15:49:27"
  ["add_date"]=>
  string(19) "2020-03-30 15:49:27"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:48"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:48"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8650"
  ["article_id"]=>
  string(4) "8650"
  [1]=>
  string(91) "Report identifies cognitive health, eSports and personalisation as sports nutrition drivers"
  ["article_title"]=>
  string(91) "Report identifies cognitive health, eSports and personalisation as sports nutrition drivers"
  [2]=>
  string(150) "Prominent figures within the sports nutrition industry identify cognitive health, personalised nutrition and the rise of eSports amongst others in ins"
  ["short_description"]=>
  string(150) "Prominent figures within the sports nutrition industry identify cognitive health, personalised nutrition and the rise of eSports amongst others in ins"
  [3]=>
  string(208) "Prominent figures within the sports nutrition industry identify cognitive health, personalised nutrition and the rise of eSports amongst others in insights gathered discussing how best to excel in the sector."
  ["description"]=>
  string(208) "Prominent figures within the sports nutrition industry identify cognitive health, personalised nutrition and the rise of eSports amongst others in insights gathered discussing how best to excel in the sector."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(153) "https://www.nutraingredients.com/Article/2020/03/30/Brain-health-eSports-are-sports-nutrition-drivers?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(153) "https://www.nutraingredients.com/Article/2020/03/30/Brain-health-eSports-are-sports-nutrition-drivers?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-30 13:00:00"
  ["add_date"]=>
  string(19) "2020-03-30 13:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:32"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8821"
  ["article_id"]=>
  string(4) "8821"
  [1]=>
  string(168) "Rhythm Pharmaceuticals Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Setmelanotide in POMC and LEPR Deficiency Obesities"
  ["article_title"]=>
  string(168) "Rhythm Pharmaceuticals Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Setmelanotide in POMC and LEPR Deficiency Obesities"
  [2]=>
  string(150) "BOSTON, March 30, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a late-stage biopharmaceutical company aim"
  ["short_description"]=>
  string(150) "BOSTON, March 30, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a late-stage biopharmaceutical company aim"
  [3]=>
  string(246) "BOSTON, March 30, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of..."
  ["description"]=>
  string(246) "BOSTON, March 30, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/rhythm-pharmaceuticals-completes-rolling-submission-new-application-u-s-food-administration-18514.html?utm_source=ddc&utm_medium=rss&utm_campaign=Rhythm+Pharmaceuticals+Completes+Rolling+Submission+of+New+Drug+Application+to+U.S.+Food+and+Drug+Administration+for"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/rhythm-pharmaceuticals-completes-rolling-submission-new-application-u-s-food-administration-18514.html?utm_source=ddc&utm_medium=rss&utm_campaign=Rhythm+Pharmaceuticals+Completes+Rolling+Submission+of+New+Drug+Application+to+U.S.+Food+and+Drug+Administration+for"
  [15]=>
  string(19) "2020-03-30 12:04:54"
  ["add_date"]=>
  string(19) "2020-03-30 12:04:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:45"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8822"
  ["article_id"]=>
  string(4) "8822"
  [1]=>
  string(131) "Three Additional Patients with Severe COVID-19 Treated with Leronlimab in New York Medical Center Bringing the Total to 10 Patients"
  ["article_title"]=>
  string(131) "Three Additional Patients with Severe COVID-19 Treated with Leronlimab in New York Medical Center Bringing the Total to 10 Patients"
  [2]=>
  string(154) "VANCOUVER, Washington, March 30, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-sta"
  ["short_description"]=>
  string(154) "VANCOUVER, Washington, March 30, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-sta"
  [3]=>
  string(255) "VANCOUVER, Washington, March 30, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for..."
  ["description"]=>
  string(255) "VANCOUVER, Washington, March 30, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/three-additional-patients-severe-covid-19-treated-leronlimab-new-york-medical-center-bringing-total-18511.html?utm_source=ddc&utm_medium=rss&utm_campaign=Three+Additional+Patients+with+Severe+COVID-19+Treated+with+Leronlimab+in+New+York+Medical+Center+Bringing+t"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/three-additional-patients-severe-covid-19-treated-leronlimab-new-york-medical-center-bringing-total-18511.html?utm_source=ddc&utm_medium=rss&utm_campaign=Three+Additional+Patients+with+Severe+COVID-19+Treated+with+Leronlimab+in+New+York+Medical+Center+Bringing+t"
  [15]=>
  string(19) "2020-03-30 12:03:00"
  ["add_date"]=>
  string(19) "2020-03-30 12:03:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:45"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8735"
  ["article_id"]=>
  string(4) "8735"
  [1]=>
  string(72) "Alcidion enhances Patientrack software with new COVID-19 assessment tool"
  ["article_title"]=>
  string(72) "Alcidion enhances Patientrack software with new COVID-19 assessment tool"
  [2]=>
  string(150) "Clinical leads will be able to use the software information internally to gauge a site-wide view of their hospital to see all affected patients and th"
  ["short_description"]=>
  string(150) "Clinical leads will be able to use the software information internally to gauge a site-wide view of their hospital to see all affected patients and th"
  [3]=>
  string(185) "Clinical leads will be able to use the software information internally to gauge a site-wide view of their hospital to see all affected patients and their status across the hospital.&#nl"
  ["description"]=>
  string(185) "Clinical leads will be able to use the software information internally to gauge a site-wide view of their hospital to see all affected patients and their status across the hospital.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(118) "https://www.healthcareitnews.com/news/asia-pacific/alcidion-enhances-patientrack-software-new-covid-19-assessment-tool"
  ["blog_url"]=>
  string(118) "https://www.healthcareitnews.com/news/asia-pacific/alcidion-enhances-patientrack-software-new-covid-19-assessment-tool"
  [15]=>
  string(19) "2020-03-30 11:38:13"
  ["add_date"]=>
  string(19) "2020-03-30 11:38:13"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:48"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:48"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8823"
  ["article_id"]=>
  string(4) "8823"
  [1]=>
  string(175) "Seres Therapeutics Announces Completion of Enrollment in SER-109 Phase 3 ECOSPOR III Study for Recurrent Clostridium difficile Infection and Provides Clinical Pipeline Updates"
  ["article_title"]=>
  string(175) "Seres Therapeutics Announces Completion of Enrollment in SER-109 Phase 3 ECOSPOR III Study for Recurrent Clostridium difficile Infection and Provides Clinical Pipeline Updates"
  [2]=>
  string(150) "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 30, 2020-- Seres Therapeutics, Inc., (Nasdaq: MCRB) announced today that the Company has completed enroll"
  ["short_description"]=>
  string(150) "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 30, 2020-- Seres Therapeutics, Inc., (Nasdaq: MCRB) announced today that the Company has completed enroll"
  [3]=>
  string(244) "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 30, 2020-- Seres Therapeutics, Inc., (Nasdaq: MCRB) announced today that the Company has completed enrollment of its SER-109 Phase 3 clinical study, ECOSPOR III. SER-109 is an oral, first-in-field..."
  ["description"]=>
  string(244) "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 30, 2020-- Seres Therapeutics, Inc., (Nasdaq: MCRB) announced today that the Company has completed enrollment of its SER-109 Phase 3 clinical study, ECOSPOR III. SER-109 is an oral, first-in-field..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/seres-therapeutics-announces-completion-enrollment-ser-109-phase-3-ecospor-iii-study-recurrent-18504.html?utm_source=ddc&utm_medium=rss&utm_campaign=Seres+Therapeutics+Announces+Completion+of+Enrollment+in+SER-109+Phase+3+ECOSPOR+III+Study+for+Recurrent+Clostrid"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/seres-therapeutics-announces-completion-enrollment-ser-109-phase-3-ecospor-iii-study-recurrent-18504.html?utm_source=ddc&utm_medium=rss&utm_campaign=Seres+Therapeutics+Announces+Completion+of+Enrollment+in+SER-109+Phase+3+ECOSPOR+III+Study+for+Recurrent+Clostrid"
  [15]=>
  string(19) "2020-03-30 11:03:32"
  ["add_date"]=>
  string(19) "2020-03-30 11:03:32"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:45"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8551"
  ["article_id"]=>
  string(4) "8551"
  [1]=>
  string(125) "First Patient Outside U.S. Treated in Global Kevzara® (sarilumab) Clinical Trial Program for Patients with Severe COVID-19"
  ["article_title"]=>
  string(125) "First Patient Outside U.S. Treated in Global Kevzara® (sarilumab) Clinical Trial Program for Patients with Severe COVID-19"
  [2]=>
  string(150) "TARRYTOWN, N.Y. and PARIS, March 30, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi"
  ["short_description"]=>
  string(150) "TARRYTOWN, N.Y. and PARIS, March 30, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi"
  [3]=>
  string(247) "TARRYTOWN, N.Y. and PARIS, March 30, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the first patient outside of the U.S. has been treated as part of a..."
  ["description"]=>
  string(247) "TARRYTOWN, N.Y. and PARIS, March 30, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the first patient outside of the U.S. has been treated as part of a..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/first-patient-outside-u-s-treated-global-kevzara-sarilumab-clinical-trial-program-patients-severe-18499.html?utm_source=ddc&utm_medium=rss&utm_campaign=First+Patient+Outside+U.S.+Treated+in+Global+Kevzara%C2%AE+%28sarilumab%29+Clinical+Trial+Program+for+Patients"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/first-patient-outside-u-s-treated-global-kevzara-sarilumab-clinical-trial-program-patients-severe-18499.html?utm_source=ddc&utm_medium=rss&utm_campaign=First+Patient+Outside+U.S.+Treated+in+Global+Kevzara%C2%AE+%28sarilumab%29+Clinical+Trial+Program+for+Patients"
  [15]=>
  string(19) "2020-03-30 09:03:53"
  ["add_date"]=>
  string(19) "2020-03-30 09:03:53"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:18:05"
  ["create_at"]=>
  string(19) "2020-03-31 11:18:05"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}